Clinical Trial Update: Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer

View source ↗

Summary

Clinical trial update on validating the SPOT-MAS blood test using circulating tumor DNA for detecting lung cancer; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Gene Solutions | Conditions: Lung Diseases, Lung Cancer Screening | Status: NOT_YET_RECRUITING